Memorial Sloan Kettering

October 2020 Newsletter

Issue link:

Contents of this Issue


Page 2 of 3

PAGE 3 If you're 70½ or older, you can make a tax-free gift to a qualified charitable organization such as MSK. Contact your professional advisor to transfer any amount, up to $100,000 per year, directly to a qualified charitable organization and without paying income tax on the distribution. The transfer generates neither taxable income nor a tax deduction, so it's a tax-smart option for donors who don't itemize. Your gift will also be put to use today, allowing you to see the difference you're making. It's worth considering this year if you have taken advantage of this opportunity in the past. A TAX-SMART GIVING OPTION Note: It is important that your gift passes directly from your IRA to MSK. If you withdraw the amount first, your gift will count as income. Today, the images and tissue samples that define a patient's cancer are valuable pieces of a puzzle that scientists and physicians use to determine the best approach to treatment. Imagine a future when this data is transformed to its fullest potential…when it reveals new patterns that radically change the way the world understands and treats cancer. MSK MIND is this future. MSK MIND [Multi-modal INtegration of Data] is a far-reaching initiative to optimize clinical data sets. Our investigators use artificial intelligence and other advanced computing techniques to analyze MSK's massive quantity of genomic information and build a synthesized computational ecosystem. Hidden inside are answers with the power to change the lives of cancer patients, not just at MSK but around the world. Data may hold the key to cancer's mysteries, and your future gift to MSK helps us invest in this valuable work. Contact the Office of Planned Giving at or 800-688-1827 to learn more about your charitable options. MSK MIND COULD EMPOWER SCIENTISTS TO PREDICT: Changes in precancerous and cancerous cells before they happen, improving prevention and early detection. Where and when cancer will spread, creating opportunities to stop it in its tracks. How cancer will respond to drugs—helping doctors prescribe the most effective option first. Data Transforms Care

Articles in this issue

Links on this page

view archives of Memorial Sloan Kettering - October 2020 Newsletter